  See all
 |
Articles: Neuro/Psych pharmacology |
Prior Articles
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke. Modified Randomized Exposure Controlled Trial (mRECT)
Stroke, 09/14/09
Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation
Drugs & Aging, 09/14/09 Antidepressant use and colorectal cancer risk
Pharmacoepidemiology and Drug Safety, 09/11/09 Kappa-opioid ligands in the study and treatment of mood disorders
Pharmacology & Therapeutics, 09/11/09 Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: Is it time to change treatment
Pediatric Blood & Cancer, 09/11/09 Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients
Pharmacogenetics and genomics, 09/11/09 A systematic review of single Chinese herbs for Alzheimers disease treatment
Evidence-based Complementary and Alternative Medicine, 09/11/09
Free full text
Synthon announces European approvals for generic Rivastigmine
Synthon, 09/11/09
Free full text
Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database
Pharmacoepidemiology and Drug Safety, 09/11/09 A Randomized, Double-Blind, Placebo-Controlled Study of Topiramate in the Treatment of Tourette Syndrome
Journal of Neurology, Neurosurgery, and Psychiatry, 09/10/09 Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic
Clinical Pharmacokinetics, 09/10/09 Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: An open-label prospective study
World Journal of Biological Psychiatry, 09/10/09 Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
The Lancet Neurology, 09/10/09 Central nervous system medication use and incident mobility limitation in community elders: the health, aging, and body composition study
Pharmacoepidemiology and Drug Safety, 09/10/09 250 mug or 500 mug interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
The Lancet Neurology, 09/10/09 Environmental Enrichment Reduces Cocaine Seeking and Reinstatement Induced by Cues and Stress but Not by Cocaine
Neuropsychopharmacology, 09/10/09 Pharmacogenetic Testing for Guiding de novo Phenprocoumon Therapy in Stroke Patients
Cerebrovascular Diseases, 09/10/09 Treatment of Progressive Stroke with Tirofiban - Experience in 35 Patients
Cerebrovascular Diseases, 09/10/09 Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition
Neuropsychopharmacology, 09/10/09 Pharmacogenomics of antidepressant drugs
Pharmacology & Therapeutics, 09/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
